TRISHA FOLSE: Open Payments
NPI 1669583688 · THIBODAUX, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$649 in 28 payments from 9 companies in 2025. Trend: 2023 $478 · 2024 $667 · 2025 $649
Food & beverage: $474Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $340 |
| Sumitomo Pharma America, Inc. | 4 | $73 |
| Astellas Pharma US Inc | 4 | $64 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $49 |
| MILLICENT US INC | 2 | $35 |
| Evofem Biosciences, Inc. | 5 | $26 |
| Exeltis, USA Inc. | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| PFIZER INC. | 1 | $18 |
Products named: PROLIA, EVENITY, Veozah, MYFEMBREE, INTRAROSA, Phexxi, SLYND, GEMTESA.
Industry payments across LA — which companies pay providers there.
